Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1

被引:43
|
作者
Trujillo, JR [1 ]
Wang, WK [1 ]
Lee, TH [1 ]
Essex, M [1 ]
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
关键词
D O I
10.1006/viro.1996.0158
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Some neuronal-derived CD4-negative cells are susceptible to infection with human immunodeficiency virus type 1 (HIV-1). Galactosyl ceramide is an alternate receptor for HIV-1 that appears to bind in vitro to the C2, vs, V4, and V5 regions of gp 120. Amino acid variation in the vs loop of HIV-1 affects cellular tropism in CD4-positive cells, but its effect on CD4-negative cells has not been fully analyzed. Here, we describe the effect of amino acid changes in vs on the HIV-1 infection of a CD4-negative neuronal cell line, SK-N-MC. The sequence of the V3 domain was found to dramatically alter virus infectivity. Furthermore, a gp120 V3 loop neutralizing monoclonal antibody blocked HIV-1 infection on SK-N-MC cells. This data suggests that vs may also serve as a primary viral determinant for infectivity of CD4-negative cells. (C) 1996 Academic Press, Inc.
引用
收藏
页码:613 / 617
页数:5
相关论文
共 50 条
  • [41] Arginine insertion and loss of N-linked glycosylation site in HIV-1 envelope V3 region confer CXCR4-tropism
    Tsuchiya, Kiyoto
    Ode, Hirotaka
    Hayashida, Tsunefusa
    Kakizawa, Junko
    Sato, Hironori
    Oka, Shinichi
    Gatanaga, Hiroyuki
    SCIENTIFIC REPORTS, 2013, 3
  • [42] Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism
    Jiang, Xiaowei
    Feyertag, Felix
    Robertson, David L.
    PLOS ONE, 2017, 12 (10):
  • [43] SYNTHETIC MULTIMERIC PEPTIDES DERIVED FROM THE V3-LOOP OF HIV-1 GP120 BIND TO GALCER AND BLOCK HIV-1 INFECTION IN CD4-NEGATIVE MUCOSAL EPITHELIAL-CELLS
    YAHI, N
    SABATIER, JM
    BAGHDIGUIAN, S
    GONZALEZSCARANO, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 246 - 246
  • [44] Performance of an HIV-1 coreceptor tropism assay utilizing replicate V3 loop sequencing and heteroduplex analysis with capillary electrophoresis
    Baumann, R.
    Hamdan, H.
    Schwab, D.
    Robin, T.
    Vichayanonda, J.
    Kagan, R. M.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A132 - A132
  • [45] THE V3 DOMAIN IS A DETERMINANT OF SIMIAN IMMUNODEFICIENCY VIRUS-CELL TROPISM
    KIRCHHOFF, F
    MORI, K
    DESROSIERS, RC
    JOURNAL OF VIROLOGY, 1994, 68 (06) : 3682 - 3692
  • [46] Detection of functional galactosylceramide (GalCer) receptors on CD4-negative HIV-1 target cells
    Delezay, O
    Yahi, N
    Fantini, J
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1996, 5 : 192 - 202
  • [47] DOES ENVELOPE V3 PEPTIDE COMPRISE THE PRINCIPAL NEUTRALIZING DETERMINANT FOR HIV
    SLOBOD, KS
    HURWITZ, JL
    VACCINE, 1995, 13 (01) : 129 - 129
  • [48] V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies
    Laakso, Meg M.
    Lee, Fang-Hua
    Haggarty, Beth
    Agrawal, Caroline
    Nolan, Katrina M.
    Biscone, Mark
    Romano, Josephine
    Jordan, Andrea P. O.
    Leslie, George J.
    Meissner, Eric G.
    Su, Lishan
    Hoxie, James A.
    Doms, Robert W.
    PLOS PATHOGENS, 2007, 3 (08) : 1118 - 1128
  • [49] THE V3 LOOP OF HIV-1 IS NOT SUFFICIENT FOR GROWTH IN MONOCYTE-MACROPHAGES
    MALYKH, A
    LORI, F
    HALL, L
    GALLO, RC
    REITZ, MS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S42 - S42
  • [50] SYNTHETIC MULTIMERIC PEPTIDES DERIVED FROM THE PRINCIPAL NEUTRALIZATION DOMAIN (V3 LOOP) OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP120 BIND TO GALACTOSYLCERAMIDE AND BLOCK HIV-1 INFECTION IN A HUMAN CD4-NEGATIVE MUCOSAL EPITHELIAL-CELL LINE
    YAHI, N
    SABATIER, JM
    BAGHDIGUIAN, S
    GONZALEZSCARANO, F
    FANTINI, J
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 320 - 325